We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > TDP-43

News List

AC Immune and WuXi Biologics Expand Strategic Partnership contractpharma
November 11, 2020
Plan to accelerate AC Immune’s TDP-43 antibody into clinical development.
Ionis Begins ALS Clinical Trial americanpharmaceuticalreview
October 28, 2020
Ionis Pharmaceuticals announced the first patients have been dosed with ION541 (also known as BIIB105), an investigational antisense medicine being developed as a potential therapy to treat most forms of amyotrophic lateral sclerosis (ALS) regardless ...
AC Immune, UPenn to Research TDP-43 in Neurodegenerative Diseases contractpharma
August 14, 2019
TDP-43, a DNA-binding protein, is a target of growing interest for neuro-orphan indications.
Researchers define Alzheimer's-like brain disorder worldpharmanews
May 10, 2019
Researchers define Alzheimer's-like brain disorder.
Researchers define Alzheimer's-like brain disorder worldpharmanews
May 08, 2019
Researchers define Alzheimer's-like brain disorder.
Researchers define Alzheimer's-like brain disorder worldpharmanews
May 05, 2019
A brain disorder that mimics symptoms of Alzheimer's disease has been defined with recommended diagnostic criteria and guidelines for advancing future research on the condition.